Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Exchange Rate Effect (2022 - 2025)

Viking Therapeutics (VKTX) has disclosed Exchange Rate Effect for 4 consecutive years, with $9000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 112.16% to $9000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8000.0 through Dec 2025, up 94.59% year-over-year, with the annual reading at -$8000.0 for FY2025, 94.59% up from the prior year.
  • Exchange Rate Effect hit $9000.0 in Q4 2025 for Viking Therapeutics, up from -$6000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $141000.0 in Q4 2022 to a low of -$223000.0 in Q3 2022.
  • Historically, Exchange Rate Effect has averaged -$19142.9 across 4 years, with a median of -$7500.0 in 2023.
  • Biggest five-year swings in Exchange Rate Effect: skyrocketed 200.0% in 2024 and later crashed 500.0% in 2025.
  • Year by year, Exchange Rate Effect stood at $141000.0 in 2022, then crashed by 64.54% to $50000.0 in 2023, then plummeted by 248.0% to -$74000.0 in 2024, then skyrocketed by 112.16% to $9000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for VKTX at $9000.0 in Q4 2025, -$6000.0 in Q3 2025, and -$12000.0 in Q2 2025.